MedTrace Logo

Choledochoscopy Multicenter Registry

NCT02166099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2017-02-20

No results posted yet for this study

Summary

The purpose of this registry is to record information and evaluate the impact of SpyGlassTM Direct Visualization System for choledochoscopy on the management of pancreatico-biliary disorders. The registry will evaluate diagnostic performance and overall clinical management impacted by SpyGlass.

This multi-center registry has been initiated:

* To document the impact of SpyGlass Choledochoscopy in pancreatico-biliary disorders on the clinical management of pancreatico-biliary disorders including malignancies.
* To assess the sensitivity, specificity, accuracy, technical feasibility, safety and cost effectiveness of SpyGlass and compare it to other diagnostic modalities.

Conditions

  • Pancreatico-biliary Disorder

Interventions

PROCEDURE

Choledochoscopy using Digital Spyglass

Choledochoscopy using Digital Spyglass during Endoscopy

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michel Kahaleh, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-12-01
Completion
2018-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02166099 on ClinicalTrials.gov